E. R�ther

1.2k total citations
20 papers, 832 citations indexed

About

E. R�ther is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, E. R�ther has authored 20 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Neurology. Recurrent topics in E. R�ther's work include Schizophrenia research and treatment (5 papers), Neurological disorders and treatments (4 papers) and Sleep and Wakefulness Research (4 papers). E. R�ther is often cited by papers focused on Schizophrenia research and treatment (5 papers), Neurological disorders and treatments (4 papers) and Sleep and Wakefulness Research (4 papers). E. R�ther collaborates with scholars based in Germany. E. R�ther's co-authors include Gerald Huether, Göran Hajak, Stefan Cohrs, Wolfgang Jordan, Andrea Rodenbeck, Dan Zhou, R. Grohmann, L. G. Schmidt, Andreas Meier and Dirk Wedekind and has published in prestigious journals such as Psychopharmacology, Journal of Neural Transmission and European Journal of Clinical Pharmacology.

In The Last Decade

E. R�ther

20 papers receiving 785 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. R�ther Germany 14 253 238 234 185 149 20 832
Terrence Sills Canada 20 141 0.6× 317 1.3× 135 0.6× 159 0.9× 41 0.3× 36 968
Thierry Danel France 17 147 0.6× 94 0.4× 165 0.7× 144 0.8× 95 0.6× 58 711
Jaana Föhr Finland 12 221 0.9× 207 0.9× 52 0.2× 99 0.5× 227 1.5× 21 953
F. R. Funderburk United States 9 378 1.5× 122 0.5× 152 0.6× 97 0.5× 123 0.8× 15 746
Na Zhong China 18 352 1.4× 131 0.6× 123 0.5× 159 0.9× 82 0.6× 48 777
Björn Appelberg Finland 21 438 1.7× 522 2.2× 281 1.2× 198 1.1× 45 0.3× 48 1.1k
D. Maestri Italy 14 139 0.5× 166 0.7× 102 0.4× 211 1.1× 37 0.2× 22 839
Jens Westheide Germany 10 141 0.6× 271 1.1× 128 0.5× 225 1.2× 48 0.3× 13 583
Tero Hallikainen Finland 14 170 0.7× 393 1.7× 65 0.3× 239 1.3× 189 1.3× 18 1.2k
Cathrin Rohleder Germany 19 159 0.6× 184 0.8× 74 0.3× 118 0.6× 38 0.3× 43 1.0k

Countries citing papers authored by E. R�ther

Since Specialization
Citations

This map shows the geographic impact of E. R�ther's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. R�ther with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. R�ther more than expected).

Fields of papers citing papers by E. R�ther

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. R�ther. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. R�ther. The network helps show where E. R�ther may publish in the future.

Co-authorship network of co-authors of E. R�ther

This figure shows the co-authorship network connecting the top 25 collaborators of E. R�ther. A scholar is included among the top collaborators of E. R�ther based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. R�ther. E. R�ther is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohrs, Stefan, et al.. (2004). Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology. 174(3). 421–9. 125 indexed citations
2.
Cohrs, Stefan, Wolfgang Jordan, Andreas Meier, et al.. (2004). Quetiapine reduces nocturnal urinary cortisol excretion in healthy subjects. Psychopharmacology. 174(3). 414–20. 38 indexed citations
3.
Bandelow, Borwin, et al.. (2004). Early traumatic life events, parental rearing styles, family history of mental disorders, and birth risk factors in patients with social anxiety disorder. European Archives of Psychiatry and Clinical Neuroscience. 254(6). 397–405. 120 indexed citations
4.
Rodenbeck, Andrea, Stefan Cohrs, Wolfgang Jordan, et al.. (2003). The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia. Psychopharmacology. 170(4). 423–428. 75 indexed citations
5.
R�ther, E., et al.. (2002). Increased transcranial magnetic motor threshold after ECT. European Archives of Psychiatry and Clinical Neuroscience. 252(5). 250–252. 5 indexed citations
6.
Huether, Gerald, Dan Zhou, & E. R�ther. (1997). Long-term modulation of presynaptic 5-HT-output: Experimentally induced changes in cortical 5-HT-transporter density, tryptophan hydroxylase content and 5-HT innervation density. Journal of Neural Transmission. 104(10). 993–1004. 40 indexed citations
7.
Huether, Gerald, Dan Zhou, & E. R�ther. (1997). Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, ?ecstasy?) and its congeners. Journal of Neural Transmission. 104(8-9). 771–794. 86 indexed citations
8.
Staedt, J., Gabriela Stoppe, H Riemann, et al.. (1996). Lamotrigine in the treatment of nocturnal myoclonus syndrome (NMS): two case reports. Journal of Neural Transmission. 103(3). 355–361. 10 indexed citations
9.
Staedt, J., Gabriela Stoppe, H Riemann, et al.. (1995). Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS). Journal of Neural Transmission. 99(1-3). 187–193. 47 indexed citations
10.
Staedt, J., H.J. Kunert, D. Sandrock, et al.. (1995). 99mTc-HMPAO-SPECT in the diagnosis of senile dementia of Alzheimer's type ? a study under clinical routine conditions. Journal of Neural Transmission. 99(1-3). 195–211. 13 indexed citations
11.
Hartung, K, M. Fricke, Bodo Liedvogel, et al.. (1995). Significance of antibodies to cardiolipin in unselected patients with systemic lupus erythematosus: clinical and laboratory associations. Rheumatology International. 15(1). 23–29. 28 indexed citations
12.
Staedt, J., Gabriela Stoppe, D. L. Munz, et al.. (1993). Dopamine D2 receptor alteration in patients with periodic movements in sleep (nocturnal myoclonus). Journal of Neural Transmission. 93(1). 71–74. 68 indexed citations
13.
Schmauß, Max, Ronald K. Wolff, Andreas Erfurth, & E. R�ther. (1989). Tolerability of long term clozapine treatment. Psychopharmacology. 99(S1). S105–S108. 30 indexed citations
14.
Grohmann, R., et al.. (1989). Adverse effects of clozapine. Psychopharmacology. 99(S1). S101–S104. 83 indexed citations
15.
Grohmann, R., et al.. (1989). Agranulocytosis and significant leucopenia with neuroleptic drugs: results from the AM�P program. Psychopharmacology. 99(S1). S109–S112. 23 indexed citations
16.
Jungkunz, G., Norbert Nedopil, & E. R�ther. (1984). Methysergide decreases prolactin release after FK 33-824 [Tyr-D-Ala-Gly-MePhe-Met(o)-ol], a potent analogue of methionine enkephalin. A study in man. Psychopharmacology. 83(2). 210–212. 1 indexed citations
17.
Grohmann, R., Hanns Hippius, E. R�ther, et al.. (1984). Assessment of adverse drug reactions in psychiatric hospitals. European Journal of Clinical Pharmacology. 26(6). 727–734. 13 indexed citations
18.
R�ther, E., et al.. (1979). Clozapine induced increase of human plasma norepinephrine. Journal of Neural Transmission. 46(2). 175–180. 15 indexed citations
19.
20.
Markianos, Manolis & E. R�ther. (1977). Serum dopamine-?-hydroxylase in parkinsonism. Journal of Neural Transmission. 40(1). 21–25. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Terrence Sills Breakdown of academic impact, for papers by Thierry Danel Breakdown of academic impact, for papers by Jaana Föhr Breakdown of academic impact, for papers by F. R. Funderburk Breakdown of academic impact, for papers by Na Zhong Breakdown of academic impact, for papers by Björn Appelberg Breakdown of academic impact, for papers by D. Maestri Breakdown of academic impact, for papers by Jens Westheide Breakdown of academic impact, for papers by Tero Hallikainen Breakdown of academic impact, for papers by Cathrin Rohleder
Rankless by CCL
2026